Flower, M., Lomeikaite, V., Ciosi, M., Cumming, S., Morales, F., Lo, K., . . . Schwalber, A. (2019). MSH3 modifies somatic instability and disease severity in Huntington’s and myotonic dystrophy type 1. Brain (London, England : 1878), 142(7), 1876-1886. https://doi.org/10.1093/brain/awz115
Chicago Style (17th ed.) CitationFlower, Michael, et al. "MSH3 Modifies Somatic Instability and Disease Severity in Huntington’s and Myotonic Dystrophy Type 1." Brain (London, England : 1878) 142, no. 7 (2019): 1876-1886. https://doi.org/10.1093/brain/awz115.
MLA (9th ed.) CitationFlower, Michael, et al. "MSH3 Modifies Somatic Instability and Disease Severity in Huntington’s and Myotonic Dystrophy Type 1." Brain (London, England : 1878), vol. 142, no. 7, 2019, pp. 1876-1886, https://doi.org/10.1093/brain/awz115.